The stock of Doximity Inc. (NYSE:DOCS) increased by $0.37 on Tuesday to finish at $23.93, up 1.57 percent. The last five days have seen an average of 1,680,020 shares of common stock traded. 4 times new highs were reached in the current year, with a fall of -$9.63. The average number of shares traded over the last 20 days was 3,005,175, while the average volume over the last 50 days totaled 1,972,150.
DOCS stock dropped -33.03% since last month. On 08/18/23, the company’s shares reached a one-month low of $21.85. The stock touched a high of $40.12 on 02/02/23, after rallying from a low of $21.85 in 52 weeks. The price of DOCS stock has declined by -28.69% or -$9.63 this year, reaching a new high 4 times. Still, the stock price is down -40.35% from the 52-week high.
Insider Transactions
DOCS stock investors should be aware that Doximity Inc. (DOCS) stock had its last reported insider trading activity 33 days ago on Jul 28. On Jul 28, Director Cabral Timothy S sold 4,714 shares at $34.96 each. This transaction resulted in the insider making $164,787. On Jul 12, Cabral Timothy S sold 7,500 shares at a price of US$35.00. After the transaction, the insider now owns 4,714 shares. Director Cabral Timothy S had earlier sold 10,000 shares on Jul 03 for $33.80 a share. The transaction was completed for $338,050.
Valuation Metrics
Doximity Inc. (DOCS) has a trailing price-to-earnings (P/E) ratio of 42.81. Beta for the stock is 1.08. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 10.61, the price-to-book (PB) ratio of 4.70, and the price-to-cash flow ratio of 24.84.
Financial Health
For the three months ended June 29, Doximity Inc.’s quick ratio was 7.50, while its current ratio was 7.50, indicating its ability to pay off its debt. As far as profitability goes, gross margin for the trailing twelve months is 87.70% percent. Doximity Inc.’s EBITDA margin for the year ended June 29 was 32.97%, whereas its operating margin stood at 30.50% for the same period. Based on annual data, it had gross profit of $365.56 million and revenue of $419.05 million.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. DOCS’s return on assets (ROA) during the last 12 months has been 10.80%. There was a 10.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 12.60%.
Earnings Surprise
According to Doximity Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $108.32 million, while revenues rose by 16.32% to $110.97 million. It was predicted that Doximity Inc.’s quarterly earnings would be $0.19, but it ended up being $0.15, beating the consensus by 26.70%. EBITDA was $34.66 million for the quarter. At the end of Doximity Inc.’s most recent quarter ended June 29, its liabilities totaled 162.72 million, while its total debt was $15.63 million. Equity owned by shareholders amounts to $194.71 million.
Technical Picture
Here’s a quick look at Doximity Inc.’s (DOCS) price momentum from a technical perspective. As of 29 August, the RSI 9-day stood at 36.69%, suggesting the stock is Neutral, with a 25.95% historical volatility rate.
The stochastic %K and %D were 35.23% and 23.29% respectively, while the average true range (ATR) was 1.01. Based on the 14-day stochastic reading of 54.17%, the RSI (14) reading is 33.57%. On the 9-day MACD Oscillator, the stock is at 0.42, and the 14-day reading is at 0.36.
Analyst Ratings
Doximity Inc. (NYSE: DOCS) was downgraded by Needham to a a Hold rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Doximity Inc. (DOCS) an Hold rating. DOCS is a stock that is recommended for selling by 2 brokerage firms, while 8 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 2 rates it overweight and 4 others recommend it as a buy.
What is DOCS’s price target for the next 12 months?
The current consensus forecast for the stock is between $21.00 and $47.00, with a median target price of $27.50. In analyzing these forecasts, the average price target given by analysts for Doximity Inc. (DOCS) is $30.25.
